Connect with us

Technology

Intel tries to take down Apple’s M1 chip with a flurry of benchmarks – Yahoo Finance Australia

Intel has shared a slew of benchmarks in a bid to downplay Apple’s M1 chip, although it’s not the resounding victory it appears to be at first.

Published

on

post featured image

MALVERN, Pa., Feb. 07, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced that it has entered into definitive agreements with healthcare-focused institutional investors for the sale of an aggregate of 3,000,000 shares of its common stock at a purchase price of $7.65 per share in a registered direct offering. The…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending